T1	Participants 92 155	adolescents with autism spectrum disorders and comorbid anxiety
T2	Participants 272 400	adolescents with high-functioning autism spectrum disorders (ASDs) and co-occurring anxiety relative to treatment as usual (TAU)
T3	Participants 409 486	Thirty-one children (11-16 years) with ASD and clinically significant anxiety
